We’re delighted that Amiculum has become a member of Bionow, joining a collaborative community that plays an important role ...
Angelini Pharma has announced that it will acquire Catalyst Pharmaceuticals in a deal worth around $4.1bn (3.5bn euros).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results